Related Experiment Video
Updated: Dec 15, 2025

Novel and Innovative Hybrid Technique for Type A Aortic Dissection
Published on: March 28, 2025
Aortic thrombus in patients with severe COVID-19: review of three cases
María de Carranza1, Danilo-Eduardo Salazar2, Jesús Troya3
1Department of Internal Medicine, Hospital Universitario Infanta Leonor, Infanta Leonor, University Hospital, Avenida Gran Vía Este 80, 28031, Madrid, Spain. mariadecarranzalopez@gmail.com.
Insights
Severe COVID-19 can cause blood clots in unusual places, including the aorta. This study highlights three cases of aortic thrombosis in patients with SARS-CoV-2 infection, emphasizing the virus's pro-coagulant effects.
Area of Science:
- Cardiovascular Medicine
- Infectious Diseases
- Hematology
Background:
- Coronavirus disease 2019 (COVID-19) is linked to an increased risk of both venous and arterial thromboembolism.
- Severe COVID-19 can trigger an exaggerated immune response, contributing to a pro-coagulant state.
- Thrombosis in atypical locations, such as the aorta, is a rare but serious complication associated with SARS-CoV-2 infection.
Observation:
- This report details three cases of patients with confirmed SARS-CoV-2 infection who developed aortic thrombi.
- Diagnosis of aortic clots was established using computed tomography (CT) angiography.
- These cases underscore the potential for COVID-19 to induce thrombosis in unusual vascular sites.
Findings:
- COVID-19 predisposes patients to thromboembolic events, including rare aortic clots.
- Severe coagulation abnormalities in SARS-CoV-2 patients warrant consideration for thrombosis in atypical locations.
- The pro-coagulant nature of COVID-19 contributes to the occurrence of aortic thrombosis.
Implications:
- Clinicians should consider aortic thrombosis in SARS-CoV-2 infected patients presenting with severe coagulation derangements.
- Early recognition and management of atypical thrombosis are crucial for improving outcomes in severe COVID-19.
- This finding expands the understanding of vascular complications associated with SARS-CoV-2 infection.
Abstract:
Coronavirus disease 2019 (COVID-19) could predispose to both venous and arterial thromboembolism, in an exaggerated immune response to the virus, especially in severe patients. Even though aortic clots are a rare entity, the pro-coagulant nature of COVID-19 is associated with thrombosis in atypical locations and should be considered in patients with severe abnormalities in coagulation parameters. We describe a series of three cases of aortic thrombi diagnosed by computerized tomography (CT) angiography in patients with confirmed SARS-CoV-2 infection.
Related Concept Videos
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Aortic Regurgitation III: Medical Management
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Endocarditis III: Medical Management
Aortic Regurgitation I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
